C92.01
Acute myeloblastic leukemia, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute myeloblastic leukemia (AML) is a type of cancer that affects the blood and bone marrow. When diagnosed as being in remission, it means that the signs and symptoms of leukemia are no longer detectable after treatment. The ICD-10 code C92.01 specifically refers to cases where AML is present but in a remission phase, indicating that the disease is under control, though not necessarily cured. This condition requires regular monitoring and ongoing medical care to manage potential relapses and complications.
Causes & Symptoms
Clinical Causes: Genetic mutations within blood cells that lead to abnormal cell growth Previous exposure to chemotherapy or radiation therapy Inherited genetic syndromes increasing leukemia risk Environmental factors such as exposure to benzene or other toxins Unknown factors, as the exact cause of AML often remains unidentified
Key Symptoms: Fatigue and weakness Fever or frequent infections Easy bruising or bleeding Pale skin due to anemia Shortness of breath with exertion Swelling or tenderness in gums or other areas Unexplained weight loss
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves blood tests, including a complete blood count (CBC) that reveals abnormal numbers of white blood cells. Bone marrow biopsy is essential for confirming the presence of leukemia cells. Additional tests, such as cytogenetic analysis, help identify specific genetic mutations. When AML is in remission, regular follow-up evaluations are necessary to detect any signs of recurrence, involving blood tests, physical examinations, and bone marrow assessments.
Treatment Protocols: While AML in remission indicates that the disease is currently controlled, treatment strategies may include:
Clinical Advice & FAQs
Billing Guidance
Is C92.01 a billable ICD-10 code?
Yes, C92.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.01?
Clinical documentation must specify the nature of Acute myeloblastic leukemia, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference